血管抑素(ANG)单克隆抗体

Monoclonal Antibody to Angiostatin (ANG)

    • 血管抑素(ANG)单克隆抗体产品包装(模拟)
    • 血管抑素(ANG)单克隆抗体产品包装(模拟)
    • 血管抑素(ANG)单克隆抗体DAB staining on IHC-P; Sample: Human Liver Tissue; Primary Ab: 20µg/ml Mouse Anti-Human ANG Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
    • 血管抑素(ANG)单克隆抗体DAB staining on IHC-P;
      Sample: Human Liver Tissue
      Primary Ab: 20µg/ml Mouse Anti-Human ANG Antibody
      Control: Used PBS instead of primary antibody
      Second Ab: 2µg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
      (Catalog: SAA544Mu19)
    • MAB254Hu21.jpgWestern Blot; Sample: Lane1: Human Serum; Lane2: Human Plasma; Lane2: Human Placenta lysate Primary Ab: 0.04μg/ml Mouse Anti-Human ANG Antibody Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
    • Certificate通过ISO 9001、ISO 13485质量体系认证

    特异性

    该抗体是针对ANG的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别ANG。

    用法

    Western blotting: 0.01-2µg/mL;
    Immunohistochemistry: 5-20µg/mL;
    Optimal working dilutions must be determined by end user.

    储存

    经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

    稳定性

    热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

    赠品

    相关产品

    编号适用物种:Homo sapiens (Human,人)应用(仅供研究使用,不用于临床诊断!)
    RPB254Hu01血管抑素(ANG)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
    PAB254Hu01血管抑素(ANG)多克隆抗体WB
    MAB254Hu21血管抑素(ANG)单克隆抗体WB; IHC
    MAB254Hu22血管抑素(ANG)单克隆抗体WB
    MAB254Hu23血管抑素(ANG)单克隆抗体WB
    MAB254Hu24血管抑素(ANG)单克隆抗体IHC
    MAB254Hu25血管抑素(ANG)单克隆抗体IHC
    SEB254Hu血管抑素(ANG)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
    LMB254Hu血管抑素(ANG)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

    参考文献

    杂志参考文献
    Science AlertAntiangiogenic Activities of Cinnamon, Black and Green Tea Extracts on Experimentally Induced Breast Cancer in Rats[Scialert: Source]
    Respiratory ResearchStrain variation in response to lung ischemia: role of MMP-12[PubMed: 23061826]
    Blood biomarker for early blood brain barrier disruption in ischemic stroke[patent:US20170199205A1]
    Biomedicine & PharmacotherapyDevelopment of a novel bivalent baculovirus vectors for complement resistance and sustained transgene expression and its application in anti-angiogenesis …[]